These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31860701)

  • 41. Alternatives to mifepristone regimens for medical abortion.
    Pymar HC; Creinin MD
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S54-64. PubMed ID: 10944370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
    Petitet PH; Ith L; Cockroft M; Delvaux T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The learning curve is rapid in medical termination of pregnancy--first-year results from the Helsinki area.
    Suhonen S; Heikinheimo O; Tikka M; Haukkamaa M
    Contraception; 2003 Mar; 67(3):223-7. PubMed ID: 12618258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
    Jensen JT; Harvey SM; Beckman LJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.
    Gómez O; Borrás A; Rabanal A; Palacio M; Carceller A; Coll O; Gratacós E
    Contraception; 2010 Feb; 81(2):97-101. PubMed ID: 20103444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Benefits of a Guideline on Safe Termination of Pregnancy for Legal Indications: An Illustrative Case Report of a Hydranencephaly.
    Abdullahi ZG; Shittu OS; Koledade AK; Mohammed U; Maikudi HA; Igashi JB; Bello N
    Afr J Reprod Health; 2019 Jun; 23(2):148-151. PubMed ID: 31433602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage.
    Niinimäki M; Jouppila P; Martikainen H; Talvensaari-Mattila A
    Fertil Steril; 2006 Aug; 86(2):367-72. PubMed ID: 16764872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion.
    Tamang A; Puri M; Lama K; Shrestha P
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):104-15. PubMed ID: 25702074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Making the case for advance provision of mifepristone and misoprostol for abortion in the United States.
    Ehrenreich K; Biggs MA; Grossman D
    BMJ Sex Reprod Health; 2022 Oct; 48(4):238-242. PubMed ID: 34862207
    [No Abstract]   [Full Text] [Related]  

  • 50. Acceptability and feasibility of medical abortion in Nepal.
    Karki C; Pokharel H; Kushwaha A; Manandhar D; Bracken H; Winikoff B
    Int J Gynaecol Obstet; 2009 Jul; 106(1):39-42. PubMed ID: 19345944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Gilbert AL; Gelfand D; Fortin J; Roncari D; Goldberg AB
    Contraception; 2023 Apr; 120():109955. PubMed ID: 36634731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone.
    Tang OS; Lee SW; Ho PC
    Hum Reprod; 2002 Nov; 17(11):2865-8. PubMed ID: 12407040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medication abortion.
    Bartz D; Goldberg A
    Clin Obstet Gynecol; 2009 Jun; 52(2):140-50. PubMed ID: 19407520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful conservative management of cervical ectopic pregnancy with combination of methotrexate, mifepristone, surgical evacuation and tamponade using a double balloon three-way catheter.
    Bakour SH; Thompson PK; Khan KS
    J Obstet Gynaecol; 2005 Aug; 25(6):616-8. PubMed ID: 16234162
    [No Abstract]   [Full Text] [Related]  

  • 55. Early medical abortion in India: three studies and their implications for abortion services.
    Coyaji K
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):191-4. PubMed ID: 10846337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
    Raymond EG; Tan YL; Grant M; Benavides E; Reis M; Sacks DN; Hannum C; Frapp S; Weaver MA
    Contraception; 2018 Apr; 97(4):324-328. PubMed ID: 29242085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.
    Tsereteli T; Chong E; Louie K; Bokhua Z; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):367-71. PubMed ID: 27449873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks of pregnancy in Kazakhstan.
    Platais I; Tsereteli T; Grebennikova G; Lotarevich T; Winikoff B
    Int J Gynaecol Obstet; 2016 Sep; 134(3):268-71. PubMed ID: 27352735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Mifepristone in primary care: no impediments against its use in management of missed miscarriage].
    Leusink P; Kleiverda G
    Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.